The agreement allows manufacturers to develop, manufacture and supply generic long-acting injectable cabotegravir for treatment in 133 countries.

A new Dunnhumby study reveals loyalty is at an inflection point, as retailers grapple with evolving shopper expectations and the growing risk of homogenization.

Formulated with three essential skin-identical ceramides AP, NP and EOP, the new launches aim to help restore and maintain ...

Curated by entrepreneur Sarah Chung Park, the platform will launch with eight of Korea’s most notable beauty brands, both ...

O Positiv Health is expanding its portfolio of products with the launch of URP Vaginal Moisture + Mood. The daily supplement ...

Dentalclean, an oral care company from Brazil, is expanding its global reach with the introduction of two product lines to ...

The retailer is reportedly cutting the market coordinator job that supports some managers, as well as coach and coordinator ...